Supreme Court re­jects Pfiz­er's bid to re­view an­ti-kick­back case

The Supreme Court shot down Pfiz­er’s pe­ti­tion on Mon­day to re­view a case that pre­vents it from pro­vid­ing fi­nan­cial as­sis­tance to help Medicare ben­e­fi­cia­ries ac­cess its rare heart con­di­tion drug.

The case re­volves around tafamidis, Pfiz­er’s drug for transthyretin amy­loid car­diomy­opa­thy (AT­TR-CM), a rare con­di­tion that oc­curs when clumps of ab­nor­mal pro­teins build up in the heart, mak­ing it hard­er to pump. Symp­toms may start with fa­tigue and short­ness of breath but can be­come fa­tal, ac­cord­ing to court doc­u­ments.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER